Home » Newsletters » BioWorld Science

BioWorld Science

March 21, 2005

View Archived Issues

Clinical data on the effectiveness of tumor necrosis radioimmunotherapy in lung cancer

Cobra to supply phase I trial material to Neovacs

sanofi pasteur delivers investigational pandemic influenza vaccine to NIAID

Adherex and NCI collaborate on development of ADH-1

Psoraxine phase II study fails to meet primary endpoint

Enrollment complete in phase III SMART study of Xcytrin

Positive phase IIa results for NCX-1020 in asthma patients

Phase IIIb study provides access to Zyflo prior to commercial availability

BioLineRx inlicenses BL-1060 for fatty liver disease

Chromos Molecular Systems to acquire Anosys

New phase I data on the efficacy of PBI-1402 in anemia

New treatments for Alzheimer's disease described in patent literature

Korean researchers report novel antibacterial agents

Agents for cardiovascular diseases described in patent literature

Interactions between St. John's wort and rosiglitazone

Joint agreement for TRK-820 in Japan

Oral BCX-4208 successfully completes phase I trial

Orphan drug designation for LR-3001 in CML

Adacel vaccine recommended for approval

Antares Pharma files IND for oxybutynin ATD

Ketoconazole reported to inhibit the metabolism of temsirolimus

Inhibitory effects found with WAY-195725 in healthy volunteers

CH3-DTPA-Gd reported to improve the MRI diagnosis of brain tumors

New data support the use of rasagiline in Parkinson's disease

Degarelix reported to decrease testosterone levels in prostate cancer patients

IKKbeta inhibitor alleviates inflammation in preclinical models of arthritis

TAK-220 chosen as a clinical candidate for HIV-1 treatment

Interactions between grapefruit juice and cabergoline

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...